- Postdoc; MD, PhD
Rootwelt-Norberg’s main research focus is on genetic cardiology. She received her PhD in 2022, after defending the thesis “Disease manifestations and predictors of arrhythmia in arrhythmogenic cardiomyopathy”. Her supervisors were professor Kristina H. Haugaa and Øyvind H. Lie.
Rootwelt-Norberg has a particular interest in risk stratification of life-threatening arrhythmias in patients with genetic cardiac diseases, and has worked mostly on research projects including arrhythmogenic cardiomyopathy, lamin A/C cardiomyopathy and arrhythmic mitral valve syndrome.
She received the Prof. J. Roelandt’s Young Investigator Award for best original work in clinical science at the 2021 EuroEcho-Imaging Congress in Berlin. The award was given for the work “Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies”.
The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy
Eur Heart J Cardiovasc Imaging (in press)
Monitoring of Myocardial Involvement in Early Arrhythmogenic Right Ventricular Cardiomyopathy Across the Age Spectrum
J Am Coll Cardiol, 82 (9), 785-797
Genetics in Probands With Idiopathic Ventricular Fibrillation: A Multicenter Study
JACC Clin Electrophysiol, 9 (8 Pt 1), 1296-1306
Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study
Europace, 25 (2), 634-642
Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy
Circ Arrhythm Electrophysiol, 15 (2), e010221
Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy
Europace, 24 (2), 306-312
Cardiac desmosomal reserve: another piece of the exercise-induced arrhythmogenic cardiomyopathy puzzle?
Eur Heart J, 43 (12), 1265-1267
Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies-External validation of the LMNA-risk ventricular tachyarrhythmia calculator
Heart Rhythm, 20 (3), 423-429
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy
Eur Heart J, 43 (45), 4694-4703
Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy: Association With Life-Threatening Ventricular Arrhythmias
JACC Cardiovasc Imaging, 14 (5), 900-910
Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis
J Am Heart Assoc, 10 (8), e018680
Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy
Europace, 23 (7), 1084-1091
Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study
JACC Cardiovasc Imaging, 11 (10), 1377-1386
Life-threatening arrhythmic presentation in patients with arrhythmogenic cardiomyopathy before and after entering the genomic era; a two-decade experience from a large volume center
Int J Cardiol, 279, 79-83